Cargando…

Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study

AIMS: This study aimed to assess the utility of contemporary clinical risk scores and explore the ability of two biomarkers [growth differentiation factor‐15 (GDF‐15) and soluble ST2 (sST2)] to improve risk prediction in elderly patients with cardiogenic shock. METHODS AND RESULTS: Patients (n = 219...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hongisto, Mari, Lassus, Johan, Tarvasmäki, Tuukka, Sionis, Alessandro, Sans‐Rosello, Jordi, Tolppanen, Heli, Kataja, Anu, Jäntti, Toni, Sabell, Tuija, Lindholm, Matias Greve, Banaszewski, Marek, Silva Cardoso, Jose, Parissis, John, Di Somma, Salvatore, Carubelli, Valentina, Jurkko, Raija, Masip, Josep, Harjola, Veli‐Pekka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006692/ https://www.ncbi.nlm.nih.gov/pubmed/33522124 http://dx.doi.org/10.1002/ehf2.13224

Ejemplares similares

Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
por: Sabell, Tuija, et al.
Publicado: (2020)

Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock( )
por: Hongisto, Mari, et al.
Publicado: (2022)

Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock
por: Jäntti, Toni, et al.
Publicado: (2021)

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock
por: Jäntti, Toni, et al.
Publicado: (2019)

Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
por: Tolppanen, Heli, et al.
Publicado: (2017)

Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
por: Tarvasmäki, Tuukka, et al.
Publicado: (2016)

Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock
por: Hänninen, Mikko, et al.
Publicado: (2020)

Circulating levels of microRNA 423‐5p are associated with 90 day mortality in cardiogenic shock
por: Jäntti, Toni, et al.
Publicado: (2018)

PRospective REgistry of PAtients in REfractory cardiogenic shock—The PREPARE CardShock registry
por: von Lewinski, Dirk, et al.
Publicado: (2022)

Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Jäntti, Toni, et al.
Publicado: (2021)

Ventricular conduction abnormalities as predictors of long‐term survival in acute de novo and decompensated chronic heart failure
por: Tolppanen, Heli, et al.
Publicado: (2015)

Pre‐hospital management protocols and perceived difficulty in diagnosing acute heart failure
por: Harjola, Pia, et al.
Publicado: (2019)

Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure
por: Öhman, Jonas, et al.
Publicado: (2017)

The emergency department arrival mode and its relations to ED management and 30-day mortality in acute heart failure: an ancillary analysis from the EURODEM study
por: Harjola, Pia, et al.
Publicado: (2022)

Early Recognition and Risk Stratification in Cardiogenic Shock: Well Begun Is Half Done
por: Polyzogopoulou, Effie, et al.
Publicado: (2023)

Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables?
por: Garcia-Osuna, Alvaro, et al.
Publicado: (2022)

Wound Shock and Surgical Shock
Publicado: (1919)

Shock about heat shock in cancer
por: de Billy, Emmanuel, et al.
Publicado: (2012)

The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022)

Shock
por: Bogossian, Levaó
Publicado: (1977)

Shock
Publicado: (1899)

Shock
Publicado: (1942)

Shock
Publicado: (1889)

Shock
Publicado: (1898)

Shock
Publicado: (1898)

Shock
por: Cheever, David W.
Publicado: (1888)

Shocking
Publicado: (1871)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Extracorporeal Shock Wave Lithotripsy for Gallstones: The Shock of the Eighties
por: Darzi, A., et al.
Publicado: (1990)

Physics of Collisionless Shocks: Space Plasma Shock Waves
por: Balogh, André, et al.
Publicado: (2013)

Is this septic shock? A rare case of distributive shock
por: Val-Flores, Luis Silva, et al.
Publicado: (2014)

Coronary Microvascular Dysfunction in Takotsubo Syndrome Assessed by Angiography-Derived Index of Microcirculatory Resistance: A Pressure-Wire-Free Tool
por: Sans-Roselló, Jordi, et al.
Publicado: (2021)

Prediction of Massive Transfusion in Trauma Patients with Shock Index, Modified Shock Index, and Age Shock Index
por: Rau, Cheng-Shyuan, et al.
Publicado: (2016)

Direct evidence of nonstationary collisionless shocks in space plasmas
por: Dimmock, Andrew P., et al.
Publicado: (2019)

Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?
por: Collado-Lledó, Elena, et al.
Publicado: (2020)

Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
por: Navas, Ana, et al.
Publicado: (2018)

Cardiogenic shock /
Publicado: (2002)

Future shock /
por: Toffler, Alvin
Publicado: (1971)

Shock III /
por: Matheson, Richard, 1926-
Publicado: (1969)

Shocking localization
por: LeBrasseur, Nicole
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_kf21onqti13vc5eqt5qr2rg0ta